CRNXNasdaq United States
Market cap
$8.918 B
$84.08 +0.19%
Close of 7 Aug 2026
Revenue
$1.04M
#3497 by revenue
Earnings
-$465.3M
Loss-making
Shares outstanding
106,065,229
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Crinetics Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.